Gynecologic Oncology

Her2+

Questions discussed in this category

In a patient with stage IVB HER2 3+ high-grade serous endometrial cancer who had disease confined to a polyp and "microscopic" omental metastases, how long would you continue maintenance trastuzumab after chemotherapy?

1 Answer available

If a patient with HER2+ uterine serous carcinoma recurs while on maintenance trastuzumab, would you continue trastuzumab with second line chemotherapy?

Given data from metastatic breast cancer trials that show benefit with continuing trastuzumab despite progression.

2 Answers available

Papers discussed in this category

N Engl J Med, 2022 Jan 19

Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer.

Gynecol Oncol, 2020 Nov 05

Uterine serous carcinoma: Molecular features, clinical management, and new and future therapies.

Related Topics in Gynecologic Oncology